Should You Buy Castellum, Inc. Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Castellum, Inc. (CTM) occupies a solid middle-ground position with a Quality of Company score of 6.3/10. At the current market price of $0.61, the investment case depends heavily on whether our 13 independent valuation models indicate a discount to fair value.
The short answer: 1 of 3 CirclFi valuation models project upside for Castellum, Inc. (CTM) at $0.61 — the model consensus leans bearish, with a Quality Score of 6.3/10 and Value-Trap risk of 30/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Castellum, Inc. (CTM) in 2026?
What Is the Bull Case vs the Bear Case for Castellum, Inc. (CTM)?
| Bull case — $0.65 target (+7.0%) | Bear case — $0.14 target (-77.4%) |
|---|---|
| Industry tailwind: enterprise adoption could provide meaningful support for Castellum, Inc.'s revenue and margin trajectory in the Information Technology Services space. | According to the CirclFi Deep Alpha Valuation Engine, the Regime Cross-Sectional model sees the stock as overvalued with a fair value of $0.14 (-77.4%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the wide model spread of +84.4% reflects fundamental divergence on key assumptions (growth, cost of capital) depending on the methodology. | |
| Industry headwind: customer churn acceleration represents a meaningful risk for Castellum, Inc. and its Information Technology Services peers. |
How Does CTM Compare to Its Information Technology Services Peers?
Valuation data pages: TTGT · GLE · GTLL · DTST · UIS · BBAI · TDTH · INOD · CDW · IT
Which Other Stocks Score Like CTM on Quality?
Closest companies to CTM’s Quality of Company score of 6.3/10, across all industries.
- CTMX — CytomX Therapeutics, Inc. (QOC 6.3) · analysis
- ORMP — Oramed Pharmaceuticals Inc. (QOC 6.3) · analysis
- VPRB — VPR Brands, LP (QOC 6.3) · analysis
- TDS — Telephone and Data Systems, Inc. (QOC 6.3) · analysis
- PETV — PetVivo Holdings, Inc. (QOC 6.3) · analysis
- CREX — Creative Realities, Inc. (QOC 6.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Information Technology Services Screens Does CTM Appear In?
So Is Castellum, Inc. (CTM) Worth Buying in 2026?
Caution dominates our read on Castellum, Inc. at $0.61. 2 of 3 models see limited upside or outright downside, with the median fair value at $0.24 (-61.3%). Quality at 6.3/10 provides some fundamental cushion. Current holders should re-evaluate their thesis; new buyers should demand a wider margin of safety.
These are quantitative model outputs, not investment recommendations. Castellum, Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About CTM Stock?
Should I buy CTM stock right now?
Based on CirclFi's multi-model analysis, 1 of 3 models see upside for CTM at $0.61. The models are divided, which means the investment case depends heavily on your assumptions about Castellum, Inc.'s future. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Castellum, Inc.?
Key risks include: limited model coverage (3/13 active), reducing analytical confidence; wide model disagreement (373% spread), signaling high uncertainty; general market and sector-specific risks affecting Information Technology Services companies. Always diversify and consult a financial advisor.
How does CTM compare to its competitors?
Among Information Technology Services peers, CTM holds a Quality Score of 6.3/10. Comparable companies include TTGT (QOC 6.4), GLE (QOC 6.2), GTLL (QOC 6.4). The relative ranking helps investors identify whether CTM offers better fundamental quality than alternatives in the same sector.
Is CTM a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. CTM's Quality Score of 6.3/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.
What price should I buy CTM at?
CirclFi does not provide target buy prices or price alerts. However, our 3 active models produce fair value estimates ranging from $0.14 to $0.65. At $0.61, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for CTM.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad